Cigna Gross Profit decreased by 1.9% to $14.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.8%, from $17.10B to $14.39B. Over 4 years (FY 2021 to FY 2025), Gross Profit shows relatively stable performance with a 1.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved pricing power or more efficient management of pharmacy and medical benefit costs, while a decrease may indicate rising medical loss ratios or competitive pressure on PBM margins.
Gross profit represents the residual profit after deducting the direct costs associated with providing pharmacy benefit...
Peers in the managed care and PBM space typically report gross profit based on the spread between premiums/service fees and the direct costs of medical claims and pharmaceutical procurement.
gross_profit| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.13B | $14.22B | $14.43B | $14.19B | $14.33B | $13.50B | $13.66B | $15.06B | $15.14B | $15.41B | $15.85B | $15.82B | $16.03B | $16.13B | $16.63B | $17.10B | $13.91B | $14.22B | $14.68B | $14.39B |
| QoQ Change | — | +0.6% | +1.5% | -1.7% | +1.0% | -5.8% | +1.1% | +10.2% | +0.6% | +1.7% | +2.9% | -0.2% | +1.3% | +0.6% | +3.1% | +2.9% | -18.7% | +2.2% | +3.2% | -1.9% |
| YoY Change | — | — | — | — | +1.4% | -5.0% | -5.4% | +6.1% | +5.7% | +14.1% | +16.1% | +5.1% | +5.9% | +4.7% | +4.9% | +8.1% | -13.2% | -11.8% | -11.7% | -15.8% |